Our in vivo capabilities span a wide range of pharmacological testing areas. We offer safety pharmacology assessments for New Chemical Entities (NCEs), supporting IND-enabling packages, and studies required for Phase 1 clinical trials.
To access the GHS report, please register on the GPC Intelligence Portal.
